BridgeBio Pharma, Inc.

Connor, Clark & Lunn Investment Management Ltd. BBIO

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/10/2026

Shares

6,347

Value ($000)

485

Weight

0.0%

2022 Q1 - 2025 Q4 (6 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/10/2026	485	0.0%	6,347	12/31/2025
2025 Q1	5/12/2025	1,252	0.0%	36,207	3/31/2025
2024 Q3	11/8/2024	309	0.0%	12,148	9/30/2024
2022 Q3	11/10/2022	499	0.0%	50,158	9/30/2022
2022 Q2	8/5/2022	153	0.0%	16,849	6/30/2022
2022 Q1	5/12/2022	3,735	0.0%	367,954	3/31/2022